Global and Region Somatostatin Market Demand & Opportunity Outlook 2022-2028

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Somatostatin is one kind of hormone. It is widely distributed throughout the body, especially in the hypothalamus and pancreas. It also acts as an important regulator of endocrine and nervous system function by inhibiting the secretion of several other hormones such as growth hormone, insulin, and gastrin.

    Somatostatin is one of the fastest growing medical Products in recent years in China. China is also the world's most rapid expansion Market. Rapid growth numbers of general hospital form a strong Market Demand of Somatostatin, especially the demand of second class and below second class hospital. As the analogue is expanding in the market, and the price of Somatostatin not decreasing so much, Somatostatin will limited in many regions, like North America and EU. Even though the analogue and regional limited, the consumption of Somatostatin is keeping quick growth rate.

    The report details the trend, potential and market size of Somatostatin market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Somatostatinmarket, defines the market attractiveness level of Somatostatin market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Somatostatin industry, describes the types of Somatostatin market, the applications of major players and the market size, and deeply analyzes the current situation of the global Somatostatin market and the development prospects and opportunities of Somatostatin industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Somatostatin market in Chapter 13.

    By Player:

    • Yangtze River

    • SANOFI-AVENTIS FRANCE

    • SAMARTH

    • Polypeptide Laboratories, Inc

    • Siyao

    • Qingdao Guoda

    • ALFA WASSERMANN SpA

    • Lyomark Pharma GmbH

    • TianTaiShan

    • Merck (Schweiz) AG

    • Chengdu Shengnuo

    • Longjin

    • Shuangcheng

    • HYBIO

    • Hainan Zhonghe

    • UBPL

    • Wuhan Hualong

    • SL PHARM

    By Type:

    • 025

    • 075

    • 3

    By End-User:

    • GI Bleeding Disease

    • Surgery

    • Other

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Somatostatin Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Somatostatin Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Somatostatin Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Somatostatin Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Somatostatin Market Analysis and Outlook to 2022

    • 7.1 Global Somatostatin Consumption (2017-2022)

    • 7.2 United States Somatostatin Consumption (2017-2022)

    • 7.3 Europe Somatostatin Consumption (2017-2022)

    • 7.4 China Somatostatin Consumption (2017-2022)

    • 7.5 Japan Somatostatin Consumption (2017-2022)

    • 7.6 India Somatostatin Consumption (2017-2022)

    • 7.7 South Korea Somatostatin Consumption (2017-2022)

    8 Region and Country-wise Somatostatin Market Analysis and Outlook to 2028

    • 8.1 Global Somatostatin Consumption Forecast (2022-2028)

    • 8.2 United States Somatostatin Consumption Forecast (2022-2028)

    • 8.3 Europe Somatostatin Consumption Forecast (2022-2028)

    • 8.4 China Somatostatin Consumption Forecast (2022-2028)

    • 8.5 Japan Somatostatin Consumption Forecast (2022-2028)

    • 8.6 India Somatostatin Consumption Forecast (2022-2028)

    • 8.7 South Korea Somatostatin Consumption Forecast (2022-2028)

    9 Global Somatostatin Market Outlook by Types and Applications to 2022

    • 9.1 Global Somatostatin Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global 025 Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global 075 Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global 3 Consumption and Growth Rate (2017-2022)

    • 9.2 Global Somatostatin Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global GI Bleeding Disease Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Surgery Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Other Consumption and Growth Rate (2017-2022)

    10 Global Somatostatin Market Outlook by Types and Applications to 2028

    • 10.1 Global Somatostatin Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global 025 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global 075 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global 3 Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Somatostatin Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global GI Bleeding Disease Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Surgery Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Other Consumption Forecast and Growth Rate (2022-2028)

    11 Global Somatostatin Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Somatostatin Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Somatostatin Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Somatostatin Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Somatostatin Market Competitive Analysis

    • 14.1 Yangtze River

      • 14.1.1 Yangtze River Company Details

      • 14.1.2 Yangtze River Somatostatin Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Yangtze River Somatostatin Product and Service

    • 14.2 SANOFI-AVENTIS FRANCE

      • 14.2.1 SANOFI-AVENTIS FRANCE Company Details

      • 14.2.2 SANOFI-AVENTIS FRANCE Somatostatin Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 SANOFI-AVENTIS FRANCE Somatostatin Product and Service

    • 14.3 SAMARTH

      • 14.3.1 SAMARTH Company Details

      • 14.3.2 SAMARTH Somatostatin Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 SAMARTH Somatostatin Product and Service

    • 14.4 Polypeptide Laboratories, Inc

      • 14.4.1 Polypeptide Laboratories, Inc Company Details

      • 14.4.2 Polypeptide Laboratories, Inc Somatostatin Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Polypeptide Laboratories, Inc Somatostatin Product and Service

    • 14.5 Siyao

      • 14.5.1 Siyao Company Details

      • 14.5.2 Siyao Somatostatin Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Siyao Somatostatin Product and Service

    • 14.6 Qingdao Guoda

      • 14.6.1 Qingdao Guoda Company Details

      • 14.6.2 Qingdao Guoda Somatostatin Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Qingdao Guoda Somatostatin Product and Service

    • 14.7 ALFA WASSERMANN SpA

      • 14.7.1 ALFA WASSERMANN SpA Company Details

      • 14.7.2 ALFA WASSERMANN SpA Somatostatin Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 ALFA WASSERMANN SpA Somatostatin Product and Service

    • 14.8 Lyomark Pharma GmbH

      • 14.8.1 Lyomark Pharma GmbH Company Details

      • 14.8.2 Lyomark Pharma GmbH Somatostatin Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Lyomark Pharma GmbH Somatostatin Product and Service

    • 14.9 TianTaiShan

      • 14.9.1 TianTaiShan Company Details

      • 14.9.2 TianTaiShan Somatostatin Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 TianTaiShan Somatostatin Product and Service

    • 14.10 Merck (Schweiz) AG

      • 14.10.1 Merck (Schweiz) AG Company Details

      • 14.10.2 Merck (Schweiz) AG Somatostatin Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Merck (Schweiz) AG Somatostatin Product and Service

    • 14.11 Chengdu Shengnuo

      • 14.11.1 Chengdu Shengnuo Company Details

      • 14.11.2 Chengdu Shengnuo Somatostatin Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Chengdu Shengnuo Somatostatin Product and Service

    • 14.12 Longjin

      • 14.12.1 Longjin Company Details

      • 14.12.2 Longjin Somatostatin Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Longjin Somatostatin Product and Service

    • 14.13 Shuangcheng

      • 14.13.1 Shuangcheng Company Details

      • 14.13.2 Shuangcheng Somatostatin Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 Shuangcheng Somatostatin Product and Service

    • 14.14 HYBIO

      • 14.14.1 HYBIO Company Details

      • 14.14.2 HYBIO Somatostatin Sales, Price, Value and Gross Profit (2017-2022)

      • 14.14.3 HYBIO Somatostatin Product and Service

    • 14.15 Hainan Zhonghe

      • 14.15.1 Hainan Zhonghe Company Details

      • 14.15.2 Hainan Zhonghe Somatostatin Sales, Price, Value and Gross Profit (2017-2022)

      • 14.15.3 Hainan Zhonghe Somatostatin Product and Service

    • 14.16 UBPL

      • 14.16.1 UBPL Company Details

      • 14.16.2 UBPL Somatostatin Sales, Price, Value and Gross Profit (2017-2022)

      • 14.16.3 UBPL Somatostatin Product and Service

    • 14.17 Wuhan Hualong

      • 14.17.1 Wuhan Hualong Company Details

      • 14.17.2 Wuhan Hualong Somatostatin Sales, Price, Value and Gross Profit (2017-2022)

      • 14.17.3 Wuhan Hualong Somatostatin Product and Service

    • 14.18 SL PHARM

      • 14.18.1 SL PHARM Company Details

      • 14.18.2 SL PHARM Somatostatin Sales, Price, Value and Gross Profit (2017-2022)

      • 14.18.3 SL PHARM Somatostatin Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Somatostatin

    • Figure Somatostatin Picture

    • Table Global Somatostatin Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Somatostatin Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Somatostatin Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Somatostatin Consumption by Country (2017-2022)

    • Figure United States Somatostatin Consumption and Growth Rate (2017-2022)

    • Table Europe Somatostatin Consumption and Growth Rate (2017-2022)

    • Figure China Somatostatin Consumption and Growth Rate (2017-2022)

    • Figure Japan Somatostatin Consumption and Growth Rate (2017-2022)

    • Figure India Somatostatin Consumption and Growth Rate (2017-2022)

    • Figure South Korea Somatostatin Consumption and Growth Rate (2017-2022)

    • Figure Global Somatostatin Consumption Forecast by Country (2022-2028)

    • Figure United States Somatostatin Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Somatostatin Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Somatostatin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Somatostatin Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Somatostatin Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Somatostatin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global 025 Consumption and Growth Rate (2017-2022)

    • Figure Global 075 Consumption and Growth Rate (2017-2022)

    • Figure Global 3 Consumption and Growth Rate (2017-2022)

    • Figure Global GI Bleeding Disease Consumption and Growth Rate (2017-2022)

    • Figure Global Surgery Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global 025 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global 075 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global 3 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global GI Bleeding Disease Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Surgery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Somatostatin Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Somatostatin Export by Region (Top 5 Countries) (2017-2028)

    • Table Yangtze River (Foundation Year, Company Profile and etc.)

    • Table Yangtze River Somatostatin Sales, Price, Value and Gross Profit (2017-2022)

    • Table Yangtze River Somatostatin Product and Service

    • Table SANOFI-AVENTIS FRANCE (Foundation Year, Company Profile and etc.)

    • Table SANOFI-AVENTIS FRANCE Somatostatin Sales, Price, Value and Gross Profit (2017-2022)

    • Table SANOFI-AVENTIS FRANCE Somatostatin Product and Service

    • Table SAMARTH (Foundation Year, Company Profile and etc.)

    • Table SAMARTH Somatostatin Sales, Price, Value and Gross Profit (2017-2022)

    • Table SAMARTH Somatostatin Product and Service

    • Table Polypeptide Laboratories, Inc (Foundation Year, Company Profile and etc.)

    • Table Polypeptide Laboratories, Inc Somatostatin Sales, Price, Value and Gross Profit (2017-2022)

    • Table Polypeptide Laboratories, Inc Somatostatin Product and Service

    • Table Siyao (Foundation Year, Company Profile and etc.)

    • Table Siyao Somatostatin Sales, Price, Value and Gross Profit (2017-2022)

    • Table Siyao Somatostatin Product and Service

    • Table Qingdao Guoda (Foundation Year, Company Profile and etc.)

    • Table Qingdao Guoda Somatostatin Sales, Price, Value and Gross Profit (2017-2022)

    • Table Qingdao Guoda Somatostatin Product and Service

    • Table ALFA WASSERMANN SpA (Foundation Year, Company Profile and etc.)

    • Table ALFA WASSERMANN SpA Somatostatin Sales, Price, Value and Gross Profit (2017-2022)

    • Table ALFA WASSERMANN SpA Somatostatin Product and Service

    • Table Lyomark Pharma GmbH (Foundation Year, Company Profile and etc.)

    • Table Lyomark Pharma GmbH Somatostatin Sales, Price, Value and Gross Profit (2017-2022)

    • Table Lyomark Pharma GmbH Somatostatin Product and Service

    • Table TianTaiShan (Foundation Year, Company Profile and etc.)

    • Table TianTaiShan Somatostatin Sales, Price, Value and Gross Profit (2017-2022)

    • Table TianTaiShan Somatostatin Product and Service

    • Table Merck (Schweiz) AG (Foundation Year, Company Profile and etc.)

    • Table Merck (Schweiz) AG Somatostatin Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck (Schweiz) AG Somatostatin Product and Service

    • Table Chengdu Shengnuo (Foundation Year, Company Profile and etc.)

    • Table Chengdu Shengnuo Somatostatin Sales, Price, Value and Gross Profit (2017-2022)

    • Table Chengdu Shengnuo Somatostatin Product and Service

    • Table Longjin (Foundation Year, Company Profile and etc.)

    • Table Longjin Somatostatin Sales, Price, Value and Gross Profit (2017-2022)

    • Table Longjin Somatostatin Product and Service

    • Table Shuangcheng (Foundation Year, Company Profile and etc.)

    • Table Shuangcheng Somatostatin Sales, Price, Value and Gross Profit (2017-2022)

    • Table Shuangcheng Somatostatin Product and Service

    • Table HYBIO (Foundation Year, Company Profile and etc.)

    • Table HYBIO Somatostatin Sales, Price, Value and Gross Profit (2017-2022)

    • Table HYBIO Somatostatin Product and Service

    • Table Hainan Zhonghe (Foundation Year, Company Profile and etc.)

    • Table Hainan Zhonghe Somatostatin Sales, Price, Value and Gross Profit (2017-2022)

    • Table Hainan Zhonghe Somatostatin Product and Service

    • Table UBPL (Foundation Year, Company Profile and etc.)

    • Table UBPL Somatostatin Sales, Price, Value and Gross Profit (2017-2022)

    • Table UBPL Somatostatin Product and Service

    • Table Wuhan Hualong (Foundation Year, Company Profile and etc.)

    • Table Wuhan Hualong Somatostatin Sales, Price, Value and Gross Profit (2017-2022)

    • Table Wuhan Hualong Somatostatin Product and Service

    • Table SL PHARM (Foundation Year, Company Profile and etc.)

    • Table SL PHARM Somatostatin Sales, Price, Value and Gross Profit (2017-2022)

    • Table SL PHARM Somatostatin Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.